141.1204-CV primary prevention. How high should we set the bar ..._Prasad, Arch Intern Med.pdf | 71.64Kb | May 25 2012 |
15vs.1206-The ostial valve of the GSV_Tasch, Phlebology.pdf | 237.43Kb | May 25 2012 |
242.1205-New criteria for the sonographic Dg of a plaque ulcer in the ecICA_Muraki, ajr.pdf | 849.67Kb | May 25 2012 |
252.1204ep-CEA in ASx patients with limited life expectancy_Wallaert, Stroke.pdf | 708.29Kb | May 25 2012 |
253.1205ep-Clopidogrel load for emboli reduction in patients with Sx-CAS undergoing urgent CEA_Tsivgoulis, Stroke ++.pdf | 229.98Kb | May 25 2012 |
276.1205-Familial occurence of CAD. Coincidence or Sign of familial predisposition_Grond Ginsbach, CVD.pdf | 104.47Kb | May 25 2012 |
333.1205-Transcollateral approach for PTA of complex SFA and TFT occlusions_Zander, JVIR.pdf | 924.61Kb | May 25 2012 |
373.1205-Long term outcomes in men screened for AAA. Prospective cohort study_Duncan, bmj.pdf | 320.21Kb | May 25 2012 |
376.1205-Screening for AAA. Should we lower the intervention cut-off point .... Editorial_Andermann, bmj.pdf | 193.17Kb | May 25 2012 |
412.1205-Syncope and Raynaud's disease_Guiloff, Arch Neurol.pdf | 88.64Kb | May 25 2012 |
429.1204-Calciphylaxis in CKD and beyond_Brandenburg, Nephrol Dial Transplant.pdf | 176.56Kb | May 25 2012 |
431.1205-Fibromuscular Dysplasia_Poloskey, Circulation.pdf | 457.55Kb | May 25 2012 |
600.1205-Pulmonary embolism and Deep vein thrombosis_Goldhaber & Bounameaux, Lancet (Seminar) ++.pdf | 471.30Kb | May 25 2012 |
615.1205-Socioeconomic and occupational RF for VTE in Sweden_Zöller, Thromb Res.pdf | 157.03Kb | May 25 2012 |
616.1205-VTE in users of non-oral hormonal contraception. FU study, Denmark 2001-10_Lidegaard, bmj.pdf | 215.12Kb | May 25 2012 |
621.1205-Attitudes towards and practice of VTE prevention in general internal medicine wards. EFIM survey_Vardi, Thromb Res.pdf | 128.53Kb | May 25 2012 |
621ot.1205-Assessing the utility of VTE prophylaxis in orthopedic surgery patients. Editorial_Carrier, Ann Intern Med ++.pdf | 60.12Kb | May 25 2012 |
621ot.1205-Prolonged vs Standard-duration VTE prophylaxis in major orthopedic surgery. SR_Sobieraj, Ann Intern Med.pdf | 230.46Kb | May 25 2012 |
622ot.1205-Oral direct F.Xa inhibitors vs LMWH to prevent VTE in patients undergoing THR or TKR. SR.MA_Neumann, Ann Intern Med.pdf | 164.31Kb | May 25 2012 |
631.1205-Circulating microparticules and risk of VTE_Bucciarelli, Thromb Res.pdf | 238.77Kb | May 25 2012 |
635b.1205-External validation of a D-dimer age-adjusted cut-off for the exclusion of PE_Jaffrelot, TH.pdf | 89.98Kb | May 25 2012 |
643.1205-Fatal reperfusion injury after thrombolysis for phlegmasia cerulea dolens_Lessne, JVIR.pdf | 814.82Kb | May 25 2012 |
678.1205-1 Aspirin for Preventing the Recurrence of VTE_Becattini nejm.pdf | 616.90Kb | May 25 2012 |
678.1205-2 Aspirin and Prevention of VTE. Editorial_Becker, nejm.pdf | 540.33Kb | May 25 2012 |
690.1205-Circulating microparticules and risk of VTE_Bucciarelli, Thromb Res.pdf | 238.78Kb | May 25 2012 |
752.1205-Performance of instruments designed to measure the dimensions of pressure ulcers. SR_O'Meara, WRR.pdf | 176.89Kb | May 25 2012 |
764k.1206-Paradoxical embolism, stroke and sclerotherapy_Parsi, Phlebology.pdf | 208.16Kb | May 25 2012 |
Comments.txt | 572.00b | May 25 2012 |